Request Deal Involvement

Ligand to acquire APEIRON Biologics for $128m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Baker McKenzie

legal advisors

Baker McKenzie

Dorda Rechtsanwalte

legal advisors

Dorda Rechtsanwalte

Geistwert

legal advisors

Geistwert

McDermott Will & Emery

legal advisors

McDermott Will & Emery

KWM Communications

pr advisors

KWM Communications

LifeSci Partners

pr advisors

LifeSci Partners

E+H Rechtsanwälte (Eisenberger & Herzog)

legal advisors

E+H Rechtsanwälte (Eisenberger & Herzog)

or

Principals

APEIRON BIOLOGICS AG

target

APEIRON BIOLOGICS AG

LIGAND PHARMACEUTICALS INC

bidder

LIGAND PHARMACEUTICALS INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Ligand to acquire APEIRON Biologics for $128m.